
Sign up to save your podcasts
Or


Dr Rinath M Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.
CME information and select publications here.
By Dr. Neil Love4.9
5656 ratings
Dr Rinath M Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.
CME information and select publications here.

135 Listeners

318 Listeners

495 Listeners

67 Listeners

31 Listeners

76 Listeners

13 Listeners

17 Listeners

12 Listeners

0 Listeners

115 Listeners

57 Listeners

3,338 Listeners

196 Listeners

44 Listeners

22 Listeners

364 Listeners

189 Listeners

43 Listeners

0 Listeners